CZ300615B6 - Rychle rozpustný farmaceutický prostredek v pevné dávkové forme s prodlouženou sladkou chutí a zpusob jeho prípravy - Google Patents

Rychle rozpustný farmaceutický prostredek v pevné dávkové forme s prodlouženou sladkou chutí a zpusob jeho prípravy Download PDF

Info

Publication number
CZ300615B6
CZ300615B6 CZ20021855A CZ20021855A CZ300615B6 CZ 300615 B6 CZ300615 B6 CZ 300615B6 CZ 20021855 A CZ20021855 A CZ 20021855A CZ 20021855 A CZ20021855 A CZ 20021855A CZ 300615 B6 CZ300615 B6 CZ 300615B6
Authority
CZ
Czechia
Prior art keywords
dosage form
acid
amount
sodium
sugar
Prior art date
Application number
CZ20021855A
Other languages
Czech (cs)
English (en)
Other versions
CZ20021855A3 (cs
Inventor
Singh@Amarjit
Jain@Rajesh
Original Assignee
Panacea Biotec Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Limited filed Critical Panacea Biotec Limited
Publication of CZ20021855A3 publication Critical patent/CZ20021855A3/cs
Publication of CZ300615B6 publication Critical patent/CZ300615B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ20021855A 1999-11-30 2000-11-24 Rychle rozpustný farmaceutický prostredek v pevné dávkové forme s prodlouženou sladkou chutí a zpusob jeho prípravy CZ300615B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1514DE1999 1999-11-30

Publications (2)

Publication Number Publication Date
CZ20021855A3 CZ20021855A3 (cs) 2002-11-13
CZ300615B6 true CZ300615B6 (cs) 2009-07-01

Family

ID=11092722

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20021855A CZ300615B6 (cs) 1999-11-30 2000-11-24 Rychle rozpustný farmaceutický prostredek v pevné dávkové forme s prodlouženou sladkou chutí a zpusob jeho prípravy

Country Status (9)

Country Link
US (1) US7122198B1 (fr)
EP (1) EP1235561A2 (fr)
AU (1) AU3221401A (fr)
BR (1) BR0015994A (fr)
CZ (1) CZ300615B6 (fr)
RU (1) RU2216319C1 (fr)
UA (1) UA78485C2 (fr)
WO (1) WO2001039749A2 (fr)
ZA (1) ZA200204193B (fr)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60120710T2 (de) * 2000-08-18 2007-06-14 Pharmacia Corp. Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
EP1608341A1 (fr) * 2003-03-21 2005-12-28 Ranbaxy Laboratories, Ltd. Comprimes de metformine solubles dans l'eau
TW200637564A (en) * 2004-12-27 2006-11-01 Kowa Co Orally disintegrable solid preparation comprising povidone-iodine
TWI383809B (zh) * 2005-06-29 2013-02-01 Otsuka Pharma Co Ltd 含有西洛他唑（ｃｉｌｏｓｔａｚｏｌ）之口腔崩解粉末
EP1983827A4 (fr) * 2006-02-01 2013-07-10 Stuart L Weg Utilisation de compositions antifongiques pour traiter des conditions gastro-intestinales superieures
WO2007096906A2 (fr) * 2006-02-27 2007-08-30 Panacea Biotec Ltd. Nouvelles compositions bucco-adhésives et procédé d'élaboration desdites compositions
US20080058408A1 (en) 2006-05-19 2008-03-06 Rogowski Roberta L Low-dose doxepin for treatment of sleep disorders in elderly patients
JP2009537553A (ja) 2006-05-19 2009-10-29 ソマクソン ファーマシューティカルズ インコーポレイテッド 睡眠改善のための低用量ドキセピンの使用法
CA2687124A1 (fr) * 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Formulations de doxepine a faible dose, incluant des formulations buccales, sublinguales et a dissolution rapide, et leurs utilisations pour traiter l'insomnie
US20100179214A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
US20100179215A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
DE102007034102A1 (de) * 2007-07-21 2009-01-22 Alzchem Trostberg Gmbh Abriebfeste und rieselfähige Glycocyamin-haltige Formlinge und Verfahren zu deren Herstellung
EP2211836A2 (fr) * 2007-10-10 2010-08-04 Rubicon Research Private Limited Comprimés de chlorhydrate de mémantine à dissolution orale et au goût masqué
WO2009061780A1 (fr) * 2007-11-09 2009-05-14 Schering-Plough Limited Formulation solide à libération rapide, sa préparation et son utilisation
GB2470494B (en) * 2008-01-17 2012-08-08 Univ Holy Ghost Duquesne Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS
WO2009118589A2 (fr) 2008-03-24 2009-10-01 Wockhardt Research Centre Compositions orodispersibles de rhéine ou de diacéréine
WO2009124357A1 (fr) * 2008-04-10 2009-10-15 Malvin Leonard Eutick Formulations orales à dissolution rapide pour médicaments critiques
EP2288345B1 (fr) 2008-04-18 2015-06-10 University College Dublin National University Of Ireland, Dublin Produits psycho-pharmaceutiques
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
US20120093738A1 (en) * 2009-06-11 2012-04-19 Rubicon Research Private Limited Taste-masked oral formulations of influenza antivirals
DK3679941T3 (da) 2009-06-18 2022-11-14 Serenity Pharmaceuticals Llc Sikker indgivelse af desmopressin
BRPI1002023A2 (pt) 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
WO2012106058A2 (fr) 2011-01-31 2012-08-09 New Market Pharmaceuticals Traitements pour animaux
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US20170100328A1 (en) * 2011-02-04 2017-04-13 Joseph E. Kovarik Bioadhesive Strip and Method of Using Same
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
NZ615437A (en) * 2011-03-18 2015-08-28 Febris Bio Tech Ltd Compositions and methods for treating multi-drug resistant malaria
BR112013031406B1 (pt) 2011-06-08 2022-02-22 Lts Lohmann Therapie-Systeme Ag Tira de filme oral comestível e seu método de preparação
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
BR112014027352B1 (pt) 2012-05-02 2022-10-25 New Market Pharmaceuticals Composições farmacêuticas para a introdução sistêmica direta
WO2013175511A1 (fr) * 2012-05-24 2013-11-28 V.B. Medicare Pvt. Ltd. Compositions pharmaceutiques au goût masqué
BR112015008753A2 (pt) 2012-10-18 2017-07-04 Neuralight Hd Llc tratamento de depressão e ptsd
AU2013370966A1 (en) * 2012-12-24 2015-06-18 Neurogastrx, Inc. Methods for treating GI tract disorders
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US9844554B2 (en) 2014-06-24 2017-12-19 Neurogastrx, Inc. Prodrugs of metopimazine
CN105078914B (zh) * 2015-07-17 2018-09-18 贵州大学 左羟丙哌嗪包合物分散片及其制备方法
CN106822007B (zh) 2015-09-11 2021-12-31 西姆莱斯股份公司 口服制剂
RU2611411C1 (ru) * 2016-01-11 2017-02-21 Общество с ограниченной ответственностью "Трейдсервис" Диспергируемая в воде таблетка ацетилцистеина и способ ее изготовления
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
EP3554489A4 (fr) 2016-12-15 2020-06-17 Evoke Pharma, Inc. Traitement d'une gastroparésie modérée et grave
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
GR1009573B (el) * 2018-03-28 2019-08-12 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας Και Αναπτυξης Α.Ε. Αναβραζοντα φαρμακευτικα δισκια που περιλαμβανουν νατριοφωσφορικη υδροκορτιζονη
JP2021522299A (ja) * 2018-05-02 2021-08-30 フェリング・ベー・フェー 改良製剤
WO2019246074A1 (fr) * 2018-06-18 2019-12-26 Synergistic Therapeutics, Llc Tablette sublinguale d'antidépresseur et d'anxiolytique
AU2021244054A1 (en) * 2020-03-23 2022-10-13 Aavishkar Oral Strips Private Limited Taste masked and rapidly disintegrating ultra thin iron orodispersible film and a process thereof
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229000A2 (fr) * 1986-01-07 1987-07-15 Warner-Lambert Company Composition d'encapsulation pour gomme à mâcher et produits comestibles
EP0452268A2 (fr) * 1990-04-10 1991-10-16 Warner-Lambert Company Libération lente d'agents actifs de microcapsules bioadhésives
FR2766089A1 (fr) * 1997-07-21 1999-01-22 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229000A2 (fr) * 1986-01-07 1987-07-15 Warner-Lambert Company Composition d'encapsulation pour gomme à mâcher et produits comestibles
EP0452268A2 (fr) * 1990-04-10 1991-10-16 Warner-Lambert Company Libération lente d'agents actifs de microcapsules bioadhésives
FR2766089A1 (fr) * 1997-07-21 1999-01-22 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide

Also Published As

Publication number Publication date
CZ20021855A3 (cs) 2002-11-13
WO2001039749A2 (fr) 2001-06-07
US7122198B1 (en) 2006-10-17
UA78485C2 (en) 2007-04-10
EP1235561A2 (fr) 2002-09-04
RU2216319C1 (ru) 2003-11-20
ZA200204193B (en) 2003-05-27
BR0015994A (pt) 2002-08-06
AU3221401A (en) 2001-06-12
RU2002117306A (ru) 2004-01-20
WO2001039749A3 (fr) 2002-02-14

Similar Documents

Publication Publication Date Title
US7122198B1 (en) Fast dissolving composition with prolonged sweet taste
US5446070A (en) Compositions and methods for topical administration of pharmaceutically active agents
US5719197A (en) Compositions and methods for topical administration of pharmaceutically active agents
CA2548281C (fr) Procede de preparation de cocristaux a phase mixte avec des agents actifs
US7026360B1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients
DE69833000T2 (de) Bio-klebemittelzusammensetzungen
CN101005828B (zh) 用于经粘膜递送活性成分的包含粘膜粘附蛋白和所述活性物质的组合物
US6638528B1 (en) Compositions and methods to effect the release profile in the transdermal administration of active agents
ES2596809T3 (es) Dispositivo de administración transdérmica de fármacos que incluye un refuerzo oclusivo
US20040018241A1 (en) Bioadhesive compositions and methods for topical administration of active agents
TW541183B (en) Bioadhesive compositions and methods for topical administration of active agents
MXPA00002983A (en) Bioadhesive compositions and methods for topical administration of active agents

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of fee

Effective date: 20001124